Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 476401 - 476420 out of 485319 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AG05) vedolizumab (adm: P) | ENTYVIO 300MG/20ML INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L04AG06) alemtuzumab (adm: P) | LEMTRADA 12MG/1.2ML INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | GenzymeCorporation |
| USA | (L04AG06) alemtuzumab (adm: P) | LEMTRADA 12MG/1.2ML INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | GenzymeCorporation |
| USA | (L04AG08) ocrelizumab (adm: P) | OCREVUS 300MG/10ML | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | GenentechUSA,Inc. |
| USA | (L04AG08) ocrelizumab (adm: P) | OCREVUS 300MG/10ML | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | GenentechUSA,Inc. |
| USA | (L04AG09) emapalumab | GAMIFANT 5MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Sobi,Inc. |
| USA | (L04AG09) emapalumab | GAMIFANT 5MG/ML INJ,SOLN | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Sobi,Inc. |
| USA | (L04AG09) emapalumab | GAMIFANT 5MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Sobi,Inc. |
| USA | (L04AG09) emapalumab | GAMIFANT 5MG/ML INJ,SOLN | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Sobi,Inc. |
| USA | (L04AG11) anifrolumab (adm: P, previous atc code l04aa51. new atc 4th level l04ag valid from january 2024.) | SAPHNELO 150ML/ML INJ, SOLN | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L04AG11) anifrolumab (adm: P, previous atc code l04aa51. new atc 4th level l04ag valid from january 2024.) | SAPHNELO 150ML/ML INJ, SOLN | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L04AG14) ublituximab | BRIUMVI 25MG/ML INJ,SOLN | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Multiple Sclerosis | TGTherapeutics,Inc. |
| USA | (L04AH01) sirolimus (adm: O) | FYARRO 100MG VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AadiBioscience,Inc. |
| USA | (L04AH01) sirolimus (adm: O) | RAPAMUNE 1MG TAB | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | Pfizer,Inc. |
| USA | (L04AH01) sirolimus (adm: O) | RAPAMUNE 1MG TAB | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | Pfizer,Inc. |
| USA | (L04AH01) sirolimus (adm: O) | RAPAMUNE 2MG TAB | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | Pfizer,Inc. |
| USA | (L04AH01) sirolimus (adm: O) | RAPAMUNE 2MG TAB | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | Pfizer,Inc. |
| USA | (L04AJ01) eculizumab (adm: P) | SOLIRIS 10MG/ML 30ML VIAL | 1X30ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | AlexionPharmaceuticalsInc. |
| USA | (L04AJ01) eculizumab (adm: P) | SOLIRIS 10MG/ML 30ML VIAL | 1X30ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | AlexionPharmaceuticalsInc. |
| USA | (L04AJ02) ravulizumab (adm: P) | ULTOMIRIS 100MG/ML INJ,SOLN | 11ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | AlexionPharmaceuticalsInc. |
Pages
